Quotes 5-day view Delayed Xetra
10/21/2020
10/22/2020
10/23/2020
10/26/2020
10/27/2020
Date
42.5(c)
42.33(c)
42.425(c)
42.555(c)
41.91 Last
5 096 131
4 219 432
3 210 078
3 902 961
3 777 683 Volume
-2.57% -0.40% +0.22% +0.31% -1.52% Change
Sales 2020
42 947 M 50 817 M 50 817 M
Net income 2020
-4 852 M -5 741 M -5 741 M
Net Debt 2020
32 409 M 38 348 M 38 348 M
P/E ratio 2020
-7,02x
Yield 2020
5,68%
Sales 2021
43 350 M 51 293 M 51 293 M
Net income 2021
3 803 M 4 499 M 4 499 M
Net Debt 2021
31 257 M 36 984 M 36 984 M
P/E ratio 2021
11,7x
Yield 2021
5,70%
Capitalization
41 807 M 49 406 M 49 468 M
EV / Sales 2020
1,73x
EV / Sales 2021
1,69x
Nbr of Employees
101 168
Free-Float
100,0%
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows:
- agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ;
- OTC...
Notations Surperformance© of Bayer AG
Trading Rating : Investor Rating :
News in other languages on BAYER AG
Analyst Recommendations on BAYER AG
Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BAYER AG
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
26
Average target price
67,53 €
Last Close Price
42,56 €
Spread / Highest target
116%
Spread / Average Target
58,7%
Spread / Lowest Target
8,10%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
BAYER AG -41.55% 49 406
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
